ArticleAdvances in biochemical engineering/biotechnology2023
The Molecular Toolset and Techniques Required to Build Cyanobacterial Cell Factories.
Article in Advances in biochemical engineering/biotechnology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Cyanobacteria as a Photosynthetic Chassis for Metabolic Pathway Engineering with Heterologous Gene Expression.Current issues in molecular biology · 2026Review
- From pond to platform: howJournal of bacteriology · 2026Review
- Co-expression of auxiliary genes enhances the activity of a heterologous OBiotechnology for biofuels and bioproducts · 2025Article
- Biotechnological Applications of Cyanobacteria: Synechocystis and Synechococcus Strains.Advances in biochemical engineering/biotechnology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cyanobacteria are the only prokaryotes performing oxygenic photosynthesis, a solar-driven process which allows them to obtain electrons from water to reduce and finally assimilate carbon dioxide. Consequently, they are in the spotlight of biotechnology as photoautotrophic cell factories to generate a large variety of chemicals and biofuels in a sustainable way. Recent progress in synthetic biology has enlarged the molecular toolset to genetically engineer the metabolism of cyanobacteria, mainly targeting common model strains, such as Synechocystis sp. PCC 6803, Synechococcus elongatus PCC 7942, Synechococcus sp. PCC 7002, or Anabaena sp. PCC 7120. Nevertheless, the accessibility and flexibility of engineering cyanobacteria is still somewhat limited and less predictable compared to other biotechnologically employed microorganisms.This chapter gives a broad overview of currently available methods for the genetic modification of cyanobacterial model strains as well as more recently discovered and promising species, such as Synechococcus elongatus PCC 11801. It comprises approaches based on homologous recombination, replicative broad-host-range or strain-specific plasmids, CRISPR/Cas, as well as markerless selection. Furthermore, common and newly introduced molecular tools for gene expression regulation are presented, comprising promoters, regulatory RNAs, genetic insulators like transcription terminators, ribosome binding sites, CRISPR interference, and the utilization of heterologous RNA polymerases. Additionally, potential DNA assembly strategies, like modular cloning, are described. Finally, considerations about post-translational control via protein degradation tags and heterologous proteases, as well as small proteins working as enzyme effectors are briefly discussed.
Indexed as
Identifiers
36029350What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.